CHA ÀǰúÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • À̼±È£
  • ¼Ò ¼Ó: ºÐ´çÂ÷¿©¼ºº´¿ø
  • Àü¹®ºÐ¾ß : ¼Ò¾ÆÀÀ±Þ
  • Á÷ À§: ºñ°ø°³
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
37 (±¹¿Ü)SCI Determinants of plasma adiponectin levels in obese children
36 (±¹³»)KCI Puromycin aminonucleosideÀÇ »ç±¸Ã¼ »óÇǼ¼Æ÷¿¡ ´ëÇÑ ¿µÇâ
35 (±¹³»)KCI ¹Ì¼÷¾Æ¿¡¼­ Ãʱ⠽ºÆ®·¹½º¼º °íÇ÷´ç°ú ¿¹ÈÄ »çÀÌÀÇ ¿¬°ü¼º
34 (±¹³»)KCI ÀÏÂ÷¼º ¸é¿ª°áÇÌ Áúȯ¿¡¼­ È£Èí±â ÇÕº´Áõ
33 (±¹¿Ü)SCI RANTES Gene promoter polymorphisms are associated with bronchial hyperresponsiveness in Korea children with asthma
32 (±¹³»)±âŸ 12¼¼ ³²¾Æ¿¡¼­ ¹ß°ßµÈ ±â°üÁö Á¡¾×Ç¥ÇÇ¾ç ¾ÏÁ¾ 1·Ê
31 (±¹³»)KCI °Ç°­ÇÑ ¼Ò¾Æ¿¡¼­ ·¾Æ¾ ¾ÆµðÆ÷³ØÆ¾ ºñ¿Í Àν¶¸° ÀúÇ×¼ºÀÇ °ü°è
30 (±¹¿Ü)SCI Immunogenicity and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy infants in Korea
29 (±¹³»)±âŸ ´ÜÀϱâ°ü¿¡¼­ Á¶»çÇÑ ½Å»ý¾Æ ¹× ¼Ò¾Æ Ä­µð´ÙÇ÷ÁõÀÇ ¿ªÇÐÀû Ư¼º
28 (±¹³»)SCI Analysis of Clinical Presentations of Bruton Disease: A Review of 20 Years of Accumulated Data from Pediatric Patients at Severance Hospital
ÀÌÀüÆäÀÌÁö À̵¿ 31 32 33 34 35 36 37 38 39 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾Çհǰ­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729